Literature DB >> 30139825

HMOX1 and acute kidney injury in sickle cell anemia.

Santosh L Saraf1, Maya Viner1, Ariel Rischall1, Rasha Raslan1, Binal N Shah1, Xu Zhang1, Jin Han1,2, Michel Gowhari1, Shivi Jain1, Robert E Molokie1,3, Roberto F Machado4, James P Lash5, Victor R Gordeuk1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30139825      PMCID： PMC6182266          DOI： 10.1182/blood-2018-05-853929

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.

Authors:  N Yamada; M Yamaya; S Okinaga; K Nakayama; K Sekizawa; S Shibahara; H Sasaki
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension.

Authors:  Vincent Audard; Sébastien Homs; Anoosha Habibi; Frederic Galacteros; Pablo Bartolucci; Bertrand Godeau; Bertrand Renaud; Yves Levy; Philippe Grimbert; Philippe Lang; Christian Brun-Buisson; Laurent Brochard; Frederique Schortgen; Bernard Maitre; Armand Mekontso Dessap
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

Review 3.  Acute kidney injury and chronic kidney disease as interconnected syndromes.

Authors:  Lakhmir S Chawla; Paul W Eggers; Robert A Star; Paul L Kimmel
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

4.  Acute kidney injury in older adults.

Authors:  Sharon Anderson; Basil Eldadah; Jeffrey B Halter; William R Hazzard; Jonathan Himmelfarb; Frances McFarland Horne; Paul L Kimmel; Bruce A Molitoris; Mahadev Murthy; Ann M O'Hare; Kenneth E Schmader; Kevin P High
Journal:  J Am Soc Nephrol       Date:  2011-01       Impact factor: 10.121

5.  APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia.

Authors:  Santosh L Saraf; Binal N Shah; Xu Zhang; Jin Han; Bamidele O Tayo; Taimur Abbasi; Adam Ostrower; Elizabeth Guzman; Robert E Molokie; Michel Gowhari; Johara Hassan; Shivi Jain; Richard S Cooper; Roberto F Machado; James P Lash; Victor R Gordeuk
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

6.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

7.  Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans.

Authors:  A Guasch; C F Zayas; J R Eckman; K Muralidharan; W Zhang; L J Elsas
Journal:  J Am Soc Nephrol       Date:  1999-05       Impact factor: 10.121

8.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

9.  Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype.

Authors:  Shruti Chaturvedi; Djamila L Ghafuri; Jeffrey Glassberg; Adetola A Kassim; Mark Rodeghier; Michael R DeBaun
Journal:  Am J Hematol       Date:  2016-10-03       Impact factor: 10.047

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391
View more
  7 in total

1.  Heme A1M'ed at the kidney in sickle cell disease.

Authors:  Santosh L Saraf
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

2.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

3.  Hyperkalemia and Metabolic Acidosis Occur at a Higher eGFR in Sickle Cell Disease.

Authors:  Santosh L Saraf; Vimal K Derebail; Xu Zhang; Roberto F Machado; Victor R Gordeuk; James P Lash; Jane Little
Journal:  Kidney360       Date:  2022-02-03

Review 4.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

5.  Identification of biomarkers, immune infiltration landscape, and treatment targets of ischemia-reperfusion acute kidney injury at an early stage by bioinformatics methods.

Authors:  Ruilian You; Zhige Heyang; Yixin Ma; Peng Xia; Hua Zheng; Jianfeng Lin; Peili Ji; Limeng Chen
Journal:  Hereditas       Date:  2022-06-04       Impact factor: 2.595

Review 6.  Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases.

Authors:  Anne Grunenwald; Lubka T Roumenina; Marie Frimat
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

7.  HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review.

Authors:  Fergus W Hamilton; Julia Somers; Ruth E Mitchell; Peter Ghazal; Nicholas J Timpson
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.